Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Abiomed, Inc.
US medical device makers could potentially benefit from a proposed rule that would extend add-on payments for their technologies due to the impacts of the COVID-19 pandemic.
Immersive technologies are becoming a reality in the OR. The second part of Medtech Insight’s series on the “Future of Surgery” introduces innovators of VR simulation tech, AR surgery platforms and AR Smart Glasses, and provides insights from world-renowned AR surgeons.
April and May were full of cardiovascular professional society conferences, yielding important new research results along with announcements of major new clinical trials. Here are a few of the highlights.
Private Company Edition: The astonishing pace of venture capital investment in drug development continues with another $1.5bn in financings of $100m or more, including $152m for Pyxis and $126m for Omega. New VC funds also continue to launch, including RiverVest’s fifth fund, totaling $275m.
- Implantable Devices
- Surgical Equipment & Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- preCARDIA, Inc.